Cite
HARVARD Citation
Fujita, Y. et al. (n.d.). 2152 Exploratory analysis of predictive biomarkers of oxaliplatin versus irinotecan in combination with bevacizumab for patients with metastatic colorectal cancer in WJOG4407G study. European journal of cancer. pp. S384-. [Online].